Biosimilar Newsletter Archive
-
10.08.20 -- Biosimilar News You May Have Missed During COVID-19
10/8/2020
10/08/20 Biosimilar Development Newsletter
-
10.06.20 -- New Podcast Episodes: Data Quality For FDA Submissions, CMC Considerations For FIH Studies, And More
10/6/2020
10/06/20 Biosimilar Development Newsletter
-
10.05.20 -- Seasoned Experts Share Their Perspectives On GMP, CMC, And The FDA
10/5/2020
10/05/20 Biosimilar Development Newsletter
-
10.01.20 -- Sandoz: Critical Initiatives For A New Biosimilars Generation
10/1/2020
10/01/20 Biosimilar Development Newsletter
-
09.24.20 -- Celltrion's Bioinnovatives Shaking Up Biosimilars
9/24/2020
09/24/20 Biosimilar Development Newsletter
-
09.17.20 -- Sandoz President: Managing The COVID-19 Biologics Supply Chain
9/17/2020
09/17/20 Biosimilar Development Newsletter
-
09.16.20 -- Deliberations/Considerations/Pathways To Achieve Viral Preparedness
9/16/2020
09/16/20 Biosimilar Development Newsletter
-
09.10.20 -- Oncology Biosimilars: Prepare For A Non-Buy & Bill World
9/10/2020
09/10/20 Biosimilar Development Newsletter
-
09.03.20 -- Cardinal Health VP Reveals Biosimilar Uptake Goals
9/3/2020
09/03/20 Biosimilar Development Newsletter
-
09.01.20 -- New Podcast Episodes: Bolt Biotherapeutics On Fundraising; RNAi Beyond The Liver; Myeloid Cells In Immuno-Oncology
9/1/2020
09/01/20 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more